Assessment of endothelial function in patients with nonalcoholic fatty liver disease (Q43663978)

25 November 2017

Assessment of endothelial function in patients with nonalcoholic fatty liver disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

25 November 2017

0 references

1 reference

4

1 reference

25 November 2017

Yasar Colak

1

1 reference

25 November 2017

Ebubekir Senates

2

1 reference

25 November 2017

Atakan Yesil

3

1 reference

25 November 2017

Oguzhan Ozturk

5

1 reference

25 November 2017

Levent Doganay

6

1 reference

25 November 2017

Ender Coskunpinar

7

1 reference

25 November 2017

Ozlem Timirci Kahraman

8

1 reference

25 November 2017

Banu Mesci

9

1 reference

25 November 2017

Celal Ulasoglu

10

1 reference

25 November 2017

Ilyas Tuncer

11

1 reference

25 November 2017

3 June 2012

1 reference

25 November 2017

1 reference

25 November 2017

43

1 reference

25 November 2017

100-107

1 reference

25 November 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-012-9712-1

25 November 2017

0 references

cites work

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

The role of non-alcoholic fatty liver disease in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Dyslipidemia in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Endothelial dysfunction: a marker of atherosclerotic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Passive Smoking and Impaired Endothelium-Dependent Arterial Dilatation in Healthy Young Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: methodological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

AGA technical review on nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

American College of Endocrinology and American Diabetes Association Consensus statement on inpatient diabetes and glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Images in cardiovascular medicine. Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

The fatty liver and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Cardiovascular Risk Factors in Childhood and Carotid Artery Intima-Media Thickness in Adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9712-1

Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients

21 January 2018

1 reference

12 December 2020

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

1 reference

12 December 2020

Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease

1 reference

12 December 2020

[Non-alcoholic fatty liver disease as an atherosclerosis risk factor]

1 reference

12 December 2020

Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males

1 reference

12 December 2020

Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a practical approach to evaluation and management

1 reference

12 December 2020

Role of endothelial dysfunction in atherosclerosis

1 reference

12 December 2020

Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease

1 reference

12 December 2020

Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?

1 reference

12 December 2020

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force

1 reference

12 December 2020

10.1007/S12020-012-9712-1

Identifiers

DOI

1 reference

Dimensions Publication ID

25 November 2017

0 references

1 reference